Pfizer's Message To Wall Street: We're Doing Things Differently Now
This article was originally published in The Pink Sheet Daily
Executive Summary
Exubera's failure was a defining moment for CEO Jeff Kindler, who says the episode motivated him to transform the way Pfizer makes decisions.
You may also be interested in...
MannKind CEO Is Optimistic About Near-Term Approval of Afrezza
One industry watcher at the J.P. Morgan conference says the company is like a "teenager," there's always an explanation.
MannKind CEO Is Optimistic About Near-Term Approval of Afrezza
One industry watcher at the J.P. Morgan conference says the company is like a "teenager," there's always an explanation.
MannKind CEO Is Optimistic About Near-Term Approval Of Afrezza
MannKind CEO Alfred Mann played down a regulatory delay of the company's rapid-acting inhaled recombinant insulin product Afrezza and, in response to questions, refused to acknowledge that finding a partner could be tough, during a presentation and subsequent breakout session at the J.P. Morgan Healthcare Conference on Jan. 12